COVID-19: A case for the collection of race data in Canada and abroad.

COVID-19 coronavirus infectious disease race racialized population visible minority

Journal

Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729

Informations de publication

Date de publication:
08 Jul 2021
Historique:
entrez: 23 8 2021
pubmed: 24 8 2021
medline: 24 8 2021
Statut: epublish

Résumé

Racialized populations have consistently been shown to have poorer health outcomes worldwide. This pattern has become even more prominent in the wake of the coronavirus disease 2019 (COVID-19) pandemic. In countries where race disaggregated data are routinely collected, such as the United States and the United Kingdom, preliminary reports have identified that racialized populations are at a heightened risk of COVID-19 infection and mortality. Similar patterns are emerging in Canada but rely on proxy measures such as neighbourhood diversity to account for race, in the absence of person-level data. It follows that the collection of race disaggregated data in Canada is a crucial element in identifying individuals at risk of poorer COVID-19 outcomes and developing targeted public health interventions to mitigate risk among Canada's racialized populations. Given this continuing gap, advocating for timely access to this data is of great importance owing to the challenges that the COVID-19 pandemic has highlighted amongst racialized populations in Canada and worldwide.

Identifiants

pubmed: 34421385
doi: 10.14745/ccdr.v47i78a02
pii: 477802
pmc: PMC8340672
doi:

Types de publication

Journal Article

Langues

eng

Pagination

300-304

Déclaration de conflit d'intérêts

Competing interests None to declare.

Références

Soc Sci Med. 2009 May;68(9):1659-66
pubmed: 19286294
EClinicalMedicine. 2020 Dec;29:100630
pubmed: 33200120
Public Health. 2020 Aug;185:261-263
pubmed: 32693249
Arch Intern Med. 1993 Sep 27;153(18):2093-101
pubmed: 8379800
Lancet Respir Med. 2020 Jun;8(6):547-548
pubmed: 32401711
Paediatr Child Health. 2012 Aug;17(7):381-4
pubmed: 23904782
Int J Popul Data Sci. 2020 Sep 30;5(1):1367
pubmed: 34007882
PLoS One. 2020 Nov 2;15(11):e0241327
pubmed: 33137155
PLoS One. 2015 Sep 23;10(9):e0138511
pubmed: 26398658
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
BMC Med. 2020 Sep 4;18(1):271
pubmed: 32883276
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
Ethn Health. 2014;19(2):240-54
pubmed: 23909292
Soc Sci Med. 2014 Feb;103:7-14
pubmed: 24507906
J Med Virol. 2021 Mar;93(3):1449-1458
pubmed: 32790106
Am J Public Health. 2009 Oct;99 Suppl 2:S261-70
pubmed: 19797739
Health Rep. 2019 Jun 19;30(6):14-21
pubmed: 31216048

Auteurs

Emily Thompson (E)

Health Security Infrastructure Regional and Operations Branch, Public Health Agency of Canada, Ottawa, ON.

Rojiemiahd Edjoc (R)

Health Security Infrastructure Regional and Operations Branch, Public Health Agency of Canada, Ottawa, ON.

Nicole Atchessi (N)

Health Security Infrastructure Regional and Operations Branch, Public Health Agency of Canada, Ottawa, ON.

Megan Striha (M)

Health Security Infrastructure Regional and Operations Branch, Public Health Agency of Canada, Ottawa, ON.

Imran Gabrani-Juma (I)

Health Security Infrastructure Regional and Operations Branch, Public Health Agency of Canada, Ottawa, ON.

Thomas Dawson (T)

Health Security Infrastructure Regional and Operations Branch, Public Health Agency of Canada, Ottawa, ON.

Classifications MeSH